Integrin antagonists |
| |
| Authors: | G. P. Curley H. Blum M. J. Humphries |
| |
| Affiliation: | (1) School of Biological Sciences, University of Manchester, Oxford Road, Manchester M13 9PT (UK), GB;(2) Hoechst Marion Roussel, DG Rheumatic/Autoimmune Diseases, D-65926 Frankfurt (Germany), e-mail: Martin.Humphries@man.ac.uk, DE |
| |
| Abstract: | Integrins are a family of cell surface glycoproteins that mediate numerous cell-cell and cell-matrix interactions and are involved in biological processes such as tissue morphogenesis, leukocyte recirculation and migration, wound healing, blood clotting and immune response. Aberrant cell adhesion has been implicated in the pathogenesis of several diseases, including a number of inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease and asthma, as well as cancer and coronary heart disease. As such integrins are seen as excellent targets for the development of therapeutic agents. This report begins with an examination of the structure of integrin molecules and their ligands and then goes on to review the current state of development of antiintegrin antagonists. Received 13 April 1999; received after revision 28 May 1999; accepted 28 May 1999 |
| |
| Keywords: | . Integrins cell adhesion antagonists inflammation cancer arthritis therapeutics. |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
